dc.creator | Bonafe, CFS | |
dc.creator | Glaser, M | |
dc.creator | Voss, EW | |
dc.creator | Weber, G | |
dc.creator | Silva, JL | |
dc.date | 2000 | |
dc.date | SEP 7 | |
dc.date | 2014-12-02T16:27:35Z | |
dc.date | 2015-11-26T16:34:32Z | |
dc.date | 2014-12-02T16:27:35Z | |
dc.date | 2015-11-26T16:34:32Z | |
dc.date.accessioned | 2018-03-28T23:16:46Z | |
dc.date.available | 2018-03-28T23:16:46Z | |
dc.identifier | Biochemical And Biophysical Research Communications. Academic Press Inc, v. 275, n. 3, n. 955, n. 961, 2000. | |
dc.identifier | 0006-291X | |
dc.identifier | WOS:000089264900040 | |
dc.identifier | 10.1006/bbrc.2000.3402 | |
dc.identifier | http://www.repositorio.unicamp.br/jspui/handle/REPOSIP/76553 | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/76553 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/76553 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1271224 | |
dc.description | Bis-(8-anilinonaphthalene-1-sulfonate) (bis-ANS) causes inactivation of vesicular stomatitis virus (VSV) at micromolar concentrations while butyl-ANS and ANS are effective at concentrations one and two orders of magnitude higher, respectively. VSV fully inactivated by the combined effects of 10 mu M bis-ANS and 2.5 kbar hydrostatic pressure elicited a high titer of neutralizing antibodies. Incubation of VSV with greater than or equal to 2 M urea at atmospheric pressure caused very little virus inactivation, whereas at a pressure of 2.5 kbar, 1 M urea caused inactivation that exceeded by more than two orders of magnitude the sum of the inactivating effects produced by urea and pressure separately. Measurements of bis-ANS fluorescence showed that increasing the urea concentration reduces the pressure required to disrupt the structure. We conclude that anilinonaphthalene sulfonate compounds inactivate VSV by a mechanism similar to that produced by pressure. The most effective antiviral compound was bis-ANS which can be used for the preparation of safe viral vaccines or as an antiviral drug eventually. (C) 2000 Academic Press. | |
dc.description | 275 | |
dc.description | 3 | |
dc.description | 955 | |
dc.description | 961 | |
dc.language | en | |
dc.publisher | Academic Press Inc | |
dc.publisher | San Diego | |
dc.publisher | EUA | |
dc.relation | Biochemical And Biophysical Research Communications | |
dc.relation | Biochem. Biophys. Res. Commun. | |
dc.rights | fechado | |
dc.source | Web of Science | |
dc.subject | vesicular stomatitis virus | |
dc.subject | pressure inactivation | |
dc.subject | bis-ANS | |
dc.subject | Hydrostatic-pressure | |
dc.subject | Mosaic-virus | |
dc.subject | Coat Protein | |
dc.subject | Dissociation | |
dc.subject | Stability | |
dc.subject | Bacteriophage | |
dc.subject | Fluorescence | |
dc.subject | Association | |
dc.subject | Dependence | |
dc.subject | Components | |
dc.title | Virus inactivation by anilinonaphthalene sulfonate compounds and comparison with other ligands | |
dc.type | Artículos de revistas | |